Characterization of the Pank2-/- mouse retinal phenotype as a pre-clinical model for pantothenate kinase-associated neurodegeneration
PLOS One · 2025
DOI: 10.1371/journal.pone.0326866 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Grace Li-Na Su und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Casey Eye Institute, Oregon Health and Science University, Portland, Oregon, United States of America. Hauptthemen laut MEDLINE: Phosphotransferases (Alcohol Group Acceptor), Pantothenate Kinase-Associated Neurodegeneration, Retina, Retinal Degeneration. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, School of Medicine, Oregon Health and Science University, Foundation for the National Institutes of Health.
Abstract (Originalsprache)
Pantothenate kinase-associated neurodegeneration (PKAN) is an autosomal recessive movement and vision disorder in the neurodegeneration with brain iron accumulation family of diseases. PKAN is caused by mutations in PANK2 , encoding pantothenate kinase 2, causing an inborn error of coenzyme A metabolism and leading to iron accumulation in the basal ganglia. Peripheral pigmentary retinopathy is common in people with PKAN. The knockout murine model of the orthologous Pank2 gene is known to manifest retinal degeneration through electroretinography, pupillary response and histology analyses. Our longitudinal characterization of the retinopathy in this model reveals reduced visual performance and reduced photoreceptor thickness compared to wild-type mice. Additionally, retinal perturbations in coenzyme A metabolism and dopamine metabolism pathways mimic those previously observed in the brain. These data extend the murine ocular phenotype associated with loss of function of Pank2. With a measurable behavioral, structural and mechanistic retinal phenotype, this mouse model is an ideal pre-clinical model that can be used to evaluate therapeutics for PKAN.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Casey Eye Institute, Oregon Health and Science University, Portland, Oregon, United States of America.
- Department of Molecular and Medical Genetics, Oregon Health and Science University, Portland, Oregon, United States of America.
ORCID-Profile: Renee C Ryals
Förderung
- NIGMS NIH HHS
- School of Medicine, Oregon Health and Science University
- Foundation for the National Institutes of Health
- Achievement Rewards for College Scientists Foundation
- Spoonbill Foundation
- OHSU SOM Exploratory Research Seed Grant
- Research to Prevent Blindness
Zitieren
APA
Su, G. L., Jeong, S. Y., Wafai, D., Tschetter, W., Zhen, D., Hayflick, S. J., & Ryals, R. C. (2025). Characterization of the Pank2-/- mouse retinal phenotype as a pre-clinical model for pantothenate kinase-associated neurodegeneration. PLOS One. https://doi.org/10.1371/journal.pone.0326866
Vancouver
Su GL, Jeong SY, Wafai D, Tschetter W, Zhen D, Hayflick SJ, et al. Characterization of the Pank2-/- mouse retinal phenotype as a pre-clinical model for pantothenate kinase-associated neurodegeneration. PLOS One. 2025. doi:10.1371/journal.pone.0326866
BibTeX
@article{Su2025,
author = {Su, Grace Li-Na and Jeong, Suh Young and Wafai, Dahlia and Tschetter, Wayne and Zhen, Dolly and Hayflick, Susan J and Ryals, Renee C},
title = {Characterization of the Pank2-/- mouse retinal phenotype as a pre-clinical model for pantothenate kinase-associated neurodegeneration},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0326866}
}
EUVIMED